La cadena de opciones muestra datos clave de las opciones de acciones de Aquaron Acquisition Corp. - Rights a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Aquaron Acquisition Corp. - Rights..

Aquaron Acquisition Corp. - Rights (NASDAQ:AQUNR) Bolsa, Cadena de Opciones

Aquaron Acquisition Corp. - Rights

WIIM

ENSG

UHAL

Shares of hospital an healthcare stocks are trading lower amid concerns over Medicaid an Medicare cuts. Additionally, President Trump recently signed an executive order on healthcare price transparency.

PSTV

Plus Therapeutics shares are trading higher after the company was granted FDA Orphan Drug Designation for BMEDA-Chelated Rhenium-186 Nanoliposomes for the treatment of lung cancer with leptomeningeal metastases.

<a href="https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=969223" title="https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=969223">https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=969223</a>

Biotech

News

General

Plus Therapeutics Granted FDA Orphan Designation For BMEDA-Chelated Rhenium-186 Nanoliposomes For The Treatment Of Lung Cancer With Leptomeningeal Metastases

Energy markets popped Friday afternoon after a <a href="https://www.benzinga.com/news/global/25/02/44053592/white-house-meeting-turns-tense-as-trump-warns-zelenskyy-youre-gambling-with-world-war-iii">heated exchange</a> between former President Donald Trump, Vice President JD Vance and Ukrainian President Volodymyr Zelenskyy at the White House. 
The diplomatic clash, which centered on U.S. military aid to Ukraine and broader foreign policy tensions, could fuel investor concerns over geopolitical stability, sending energy-related assets higher.
What To Know: The Energy Select Sector SPDR Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NASDAQ">XLE</a>), which tracks major U.S. energy companies, and the United States Oil Fund LP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USO#NASDAQ">USO</a>), which follows West Texas Intermediate crude oil prices, both saw volatility amid rising uncertainty in global energy markets.
Read Also: <a href="https://www.benzinga.com/general/market-summary/25/02/44051518/nvidia-tesla-lead-tech-stock-rebound-whats-driving-markets-friday">Nvidia, Tesla Lead Tech Stock Rebound: What&#8217;s Driving Markets Friday?</a>
The friction between U.S. and Ukrainian leadership may signal a potential shift in American foreign policy, particularly regarding its support for Ukraine. Trump and Vance&#8217;s skepticism toward continued military aid raises concerns that a reduction in assistance could embolden Russia, potentially escalating the ongoing war. 
The prospect of prolonged or intensified conflict in Eastern Europe often leads to a surge in crude prices, benefiting funds like USO. Simultaneously, rising oil prices boost the profitability of U.S. energy companies, lifting stocks within XLE.
Read Also: <a href="https://www.benzinga.com/25/02/44049626/key-inflation-measure-falls-in-january-should-catch-the-feds-attention-expert-says">Key Inflation Measure Falls In January: &#8216;Should Catch The Fed&#8217;s Attention,&#8217; Economist Says</a>

Energy Markets Volatile As Trump, Vance Clash with Zelenskyy Over Ukraine Aid

Whales with a lot of money to spend have taken a noticeably bullish stance on Lemonade.
Looking at options history for Lemonade (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $233,560 and 7, calls, for a total amount of $350,204.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $17.0 and $50.0 for Lemonade, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Lemonade's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Lemonade's whale trades within a strike price range from $17.0 to $50.0 in the last 30 days. 
<h3>Lemonade Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740775617_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LMND</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/28/25</td>
<td>$9.6</td>
<td>$8.3</td>
<td>$8.45</td>
<td>$28.00</td>
<td>$168.1K</td>
<td align="right">201</td>
<td align="right">201</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$3.2</td>
<td>$3.1</td>
<td>$3.11</td>
<td>$36.00</td>
<td>$62.2K</td>
<td align="right">25</td>
<td align="right">605</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/28/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$35.00</td>
<td>$54.2K</td>
<td align="right">72</td>
<td align="right">164</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$2.6</td>
<td>$2.5</td>
<td>$2.6</td>
<td>$35.00</td>
<td>$51.9K</td>
<td align="right">147</td>
<td align="right">355</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$16.5</td>
<td>$16.3</td>
<td>$16.5</td>
<td>$45.00</td>
<td>$39.6K</td>
<td align="right">7</td>
<td align="right">25</td>
</tr>
</tbody>
</table>

<h3>About Lemonade</h3>
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.
In light of the recent options history for Lemonade, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Lemonade</h3>
<ul>
<li>With a volume of 1,905,991, the price of LMND is down -3.95% at $34.06. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 60 days.</li>
</ul>
<h3>What Analysts Are Saying About Lemonade</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $47.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler has decided to maintain their Neutral rating on Lemonade, which currently sits at a price target of $34. 
&#x2A; In a cautious move, an analyst from Citizens Capital Markets downgraded its rating to Market Outperform, setting a price target of $60. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Lemonade, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

LMND

A Closer Look at Lemonade's Options Market Dynamics

High-rolling investors have positioned themselves bearish on Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in CYTK often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 11 options trades for Cytokinetics. This is not a typical pattern.
The sentiment among these major traders is split, with 18% bullish and 72% bearish. Among all the options we identified, there was one put, amounting to $26,400, and 10 calls, totaling $2,209,345.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $45.0 to $60.0 for Cytokinetics over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Cytokinetics stands at 6050.25, with a total volume reaching 9,826.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Cytokinetics, situated within the strike price corridor from $45.0 to $60.0, throughout the last 30 days.
<h3>Cytokinetics Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740775612_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$8.3</td>
<td>$8.0</td>
<td>$8.3</td>
<td>$60.00</td>
<td>$593.4K</td>
<td>10.8K</td>
<td>1.0K</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$6.5</td>
<td>$6.1</td>
<td>$6.1</td>
<td>$50.00</td>
<td>$301.9K</td>
<td>12.9K</td>
<td>503</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$7.5</td>
<td>$6.6</td>
<td>$6.6</td>
<td>$50.00</td>
<td>$301.6K</td>
<td>12.9K</td>
<td>1.5K</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$8.4</td>
<td>$8.0</td>
<td>$8.4</td>
<td>$60.00</td>
<td>$238.5K</td>
<td>10.8K</td>
<td>297</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$6.1</td>
<td>$5.8</td>
<td>$5.8</td>
<td>$50.00</td>
<td>$233.1K</td>
<td>12.9K</td>
<td>2.0K</td>
</tr>
</tbody>
</table>

<h3>About Cytokinetics</h3>
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Following our analysis of the options activities associated with Cytokinetics, we pivot to a closer look at the company's own performance.
<h3>Where Is Cytokinetics Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,337,052, the price of CYTK is down by -6.22%, reaching $44.5.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 68 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Cytokinetics</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $84.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a positive move, an analyst from Morgan Stanley has upgraded their rating to Overweight and adjusted the price target to $67. 
&#x2A; An analyst from Citigroup has revised its rating downward to Buy, adjusting the price target to $86. 
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $72. 
&#x2A; In a cautious move, an analyst from HC Wainwright &amp; Co. downgraded its rating to Buy, setting a price target of $120. 
&#x2A; Reflecting concerns, an analyst from JMP Securities lowers its rating to Market Outperform with a new price target of $78.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cytokinetics options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

CYTK

Smart Money Is Betting Big In CYTK Options

Investors with a lot of money to spend have taken a bullish stance on Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RCL, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 18 uncommon options trades for Royal Caribbean Gr.
This isn't normal.
The overall sentiment of these big-money traders is split between 44% bullish and 38%, bearish.
Out of all of the special options we uncovered, 12 are puts, for a total amount of $904,053, and 6 are calls, for a total amount of $340,232.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $195.0 to $255.0 for Royal Caribbean Gr during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Royal Caribbean Gr's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Royal Caribbean Gr's significant trades, within a strike price range of $195.0 to $255.0, over the past month.
<h3>Royal Caribbean Gr Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740775607_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$22.15</td>
<td>$21.3</td>
<td>$22.2</td>
<td>$250.00</td>
<td>$102.1K</td>
<td align="right">195</td>
<td align="right">355</td>
</tr>
<tr>
<td>RCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$22.55</td>
<td>$22.45</td>
<td>$22.55</td>
<td>$250.00</td>
<td>$101.7K</td>
<td align="right">195</td>
<td align="right">177</td>
</tr>
<tr>
<td>RCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$21.8</td>
<td>$21.45</td>
<td>$21.77</td>
<td>$250.00</td>
<td>$100.1K</td>
<td align="right">195</td>
<td align="right">309</td>
</tr>
<tr>
<td>RCL</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$22.8</td>
<td>$22.4</td>
<td>$22.62</td>
<td>$250.00</td>
<td>$97.2K</td>
<td align="right">195</td>
<td align="right">220</td>
</tr>
<tr>
<td>RCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$21.35</td>
<td>$21.0</td>
<td>$21.35</td>
<td>$250.00</td>
<td>$97.1K</td>
<td align="right">195</td>
<td align="right">436</td>
</tr>
</tbody>
</table>

<h3>About Royal Caribbean Gr</h3>
Royal Caribbean is the world's second-largest cruise company, operating 66 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021 and plans to launch its new Celebrity River Cruise brand in 2027.
Following our analysis of the options activities associated with Royal Caribbean Gr, we pivot to a closer look at the company's own performance.
<h3>Royal Caribbean Gr's Current Market Status</h3>
<ul>
<li>With a volume of 1,713,422, the price of RCL is up 2.41% at $243.89. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 55 days.</li>
</ul>
<h3>What The Experts Say On Royal Caribbean Gr</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $281.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Royal Caribbean Gr, which currently sits at a price target of $301. 
&#x2A; Reflecting concerns, an analyst from Loop Capital lowers its rating to Hold with a new price target of $250. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Royal Caribbean Gr, which currently sits at a price target of $225. 
&#x2A; An analyst from Macquarie persists with their Outperform rating on Royal Caribbean Gr, maintaining a target price of $300. 
&#x2A; Maintaining their stance, an analyst from Tigress Financial continues to hold a Buy rating for Royal Caribbean Gr, targeting a price of $330. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Royal Caribbean Gr with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Check Out What Whales Are Doing With RCL

<h2 class="wp-block-heading">New On The Block</h2>
Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) is seeking to sell Insitu, a maker of small, long-range military drones, per <a href="https://www.bloomberg.com/news/articles/2025-02-24/boeing-seeks-buyers-for-insitu-drone-unit-in-push-to-shed-assets">Bloomberg</a>.
The Arlington County, Virginia-based aerospace company acquired Insitu in 2008. Since then, the business has gone on to make drones for various military, including Ukraine&#8217;s. The price tag? $500 million, analysts say.
Meanwhile, BP (LSE: BP) will seek to sell its Castrol lubricants business, noted <a href="https://www.bloomberg.com/news/articles/2025-02-25/bp-said-to-prepare-lubricants-sale-ditch-plan-to-cut-oil-output-in-review?srnd=phx-deals">Bloomberg</a>. It could be worth about $10 billion &#8211; a that sum that could help strengthen the company's balance sheet, which is <a href="https://www.bloomberg.com/news/articles/2025-02-18/bp-is-said-to-weigh-sale-of-lubricants-unit-with-elliott-pushing" target="_blank" rel="noreferrer noopener">reportedly</a> weaker than its peers.
Cantaloupe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTLP#NASDAQ">CTLP</a>), a Malvern, Pennsylvania-based payments processor is exploring a sale or go-private transaction, Reuters reported. Its market cap is currently $713-million.
<h2 class="wp-block-heading">Private Equity</h2>
Sycamore Partners is planning a buyout of Walgreens (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>). If it succeeds, the firm will prepare a three-part breakup, according to the <a href="https://www.ft.com/content/9087ffb1-24d5-4adc-8a57-ef123d4c4c63">Financial Times</a>. 
The private equity firm envisions three separate businesses with distinct capital structures: the U.S. retail pharmacy, Boots UK and U.S. healthcare. Each division will operate independently.
<h2 class="wp-block-heading">Updates From The Block</h2>
Seven &amp; i (TYO:<a class="ticker" href="https://www.benzinga.com/stock/TYO:3382#TYO">3382</a>), the owner of 7-Eleven, is under pressure from Artisan Partners to consider a competitive bidding process. The retailer's response to Alimentation Couche-Tard's offer is seen as a test case for Japan's evolving M&amp;A landscape.
Seven &amp; i&#8217;s founders, the Ito family, had explored a management buyout that would have been the largest in history but ultimately failed to secure financing. Meanwhile, Couche-Tard remains committed to buying Seven &amp; i&#8217;s North American stores. But Japanese franchisees are likely to resist foreign ownership. 
Despite being deemed &#8220;core&#8221; to Japan's national security, the government has stated it would not obstruct a buyout. Separately, Seven &amp; i is close to selling non-core assets to Bain Capital, according to Reuters.
<h2 class="wp-block-heading">Off The Block</h2>
TKO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>), created a year ago from the <a href="https://www.benzinga.com/general/entertainment/23/09/34455843/wwe-and-ufc-merge-on-tuesday-heres-what-you-need-to-know" target="_blank" rel="noreferrer noopener">merger of the WWE and UFC</a>, completed its purchase of IMG, On Location and Professional Bull Riders from Endeavor Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDR#NYSE">EDR</a>). The acquisition <a href="https://www.benzinga.com/m-a/24/10/41561859/deal-dispatch-ufc-wwe-parent-tko-takes-on-bull-riding-endeavor-looks-to-sell-tennis-another-car-comp">was first announced in October</a>.
<h2 class="wp-block-heading">Bankruptcy Block</h2>
Looks like even the aerospace industry isn't immune to crash landings. Dynamic Aerostructures, which makes high-tech parts for U.S. fighter jets and SpaceX rockets, <a href="https://www.benzinga.com/news/asset-sales/25/02/43994380/spacex-parts-supplier-dynamic-aerostructures-files-for-bankruptcy-bid-deadline-set">recently filed for bankruptcy</a>. The company plans to auction itself off in a court-supervised sale.
The company, backed by Endeavour Capital, blames its financial nosedive on quality-control issues, inflation-driven inventory costs and bad customer contracts. The search is on for a buyer, with an April 7 bid deadline set for potential suitors.
With $55 million in debt, FMI Aerostructures has been a key supplier for Boeing, Lockheed Martin and Northrop Grumman, including making parts for the stealthy B-2 Spirit bomber.
Fast fashion retailer Forever 21 is coming to a screeching halt. The company is expected to shutter all of its stores and liquidate its assets, Debtwire reports. A bankruptcy filing is not yet official. In the event that it is, expect the company&#8217;s workforce in shopping malls nationwide to feel the effects. Bloomberg projects that at least 200 locations are preparing to close.
<h2 class="wp-block-heading">Notes From The Block</h2>
M&amp;A activity is rising in digital health, biotech and provider groups as companies seek scale, data integration and new care models, according to consulting firm LBMC. Private equity-backed consolidations in healthcare services remain under scrutiny, while regulatory shifts and a new administration could reshape hospital and tech acquisitions.
Lisa Nix, LBMC shareholder, <a href="https://www.globenewswire.com/news-release/2025/02/26/3033266/0/en/LBMC-Unveils-Key-Healthcare-Trends-for-2025-AI-M-A-Cybersecurity-and-Policy-Shifts-Poised-to-Reshape-the-Industry.html">expects</a> a resurgence in healthcare M&amp;A in 2025, driven by declining interest rates, PE dry powder and a more lenient regulatory environment, setting the stage for transformative deals that could redefine patient care.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/real-estate/25/02/44004188/ellen-degeneres-and-portia-de-rossis-quest-for-a-uk-home-continues-after-their-18-million-farmhouse-purchase-runs-into-problems">Ellen DeGeneres and Portia de Rossi&#8217;s Quest For A UK Home Continues After Their $18 Million Farmhouse Purchase Runs into Problems</a></li>
</ul>

Asset Sales

CTLP

TYO:3382

Deal Dispatch: Boeing Done With Drones? Plus BP To Sell Lubricants, 7-Eleven Parent Nixes $58 Billion Bid

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are higher, rebounding following recent weakness.

TSLA

Tesla shares are trading higher, possibly rebounding following recent weakness.

JP Morgan CEO Jamie Dimon Says We Have 450 Use Cases For AI Now, It Could Go Up To 1,000 Use Cases By Next Year

Canadian Natural Res (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNQ#NYSE">CNQ</a>) has outperformed the market over the past 5 years by 3.51% on an annualized basis producing an average annual return of 17.93%. Currently, Canadian Natural Res has a market capitalization of $59.34 billion. 
Buying $100 In CNQ: If an investor had bought $100 of CNQ stock 5 years ago, it would be worth $220.32 today based on a price of $28.08 for CNQ at the time of writing.
<h3>Canadian Natural Res's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740774652_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Canadian Natural Res 5 Years Ago Would Be Worth Today

Entergy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) short percent of float has fallen 7.96% since its last report. The company recently reported that it has 6.98 million shares sold short, which is 1.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.43 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Entergy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740774635_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Entergy has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Entergy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Entergy's peer group average for short interest as a percentage of float is 2.41%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

What Does the Market Think About Entergy?

Ally Financial's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) short percent of float has risen 27.35% since its last report. The company recently reported that it has 8.69 million shares sold short, which is 2.84% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Ally Financial Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740774630_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ally Financial has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ally Financial's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Ally Financial's peer group average for short interest as a percentage of float is 6.90%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ALLY

What Does the Market Think About Ally Financial?

Insulet's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NYSE">PODD</a>) short percent of float has fallen 11.61% since its last report. The company recently reported that it has 2.16 million shares sold short, which is 4.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.58 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Insulet Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740774625_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Insulet has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Insulet's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Insulet's peer group average for short interest as a percentage of float is 3.97%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

PODD

What's Driving the Market Sentiment Around Insulet?

Most people know that <a href="https://www.benzinga.com/startups/25/01/42802794/there-wont-be-money-for-social-security-elon-musk-tells-joe-rogan-about-looming-bankruptcy-and-1-1-trillion-interest">Social Security</a> alone won't be enough for a comfortable retirement. The numbers don't lie—the average monthly benefit in 2025 is around $1,976, adding up to about $23,712 a year, according to<a href="https://www.ssa.gov/faqs/en/questions/KA-01903.html?utm_source=chatgpt.com"> the Social Security Administration</a>.&nbsp;
That's why so many Americans rely on personal savings, 401(k)s, and IRAs to bridge the gap. But there's still a big debate about how Social Security should work and how people should be investing for their future.
Don't Miss:
<ul>
<li>The average 401(k) balance soars to a record-breaking high – <a href="https://www.benzinga.com/money/average-401k-balances-soars-to-record-high">Here's how to know if your nest egg is keeping pace.</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>
<h2 class="wp-block-heading">Should Social Security Be Means-Tested, and How Should You Invest?</h2>
<a href="https://www.troweprice.com/personal-investing/resources/insights/how-to-determine-amount-of-income-you-will-need-at-retirement.html">According to T. Rowe Price</a>, a widely accepted guideline is to aim for a retirement income that replaces approximately 75% of your pre-retirement salary.&nbsp;
That's why employer-sponsored 401(k) plans and IRAs have become such an important part of retirement planning—they help people grow their savings and take control of their financial future.
But the way Social Security benefits are handed out has become a hot topic, and some experts think it's time for a change.
Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
Scott Galloway, an NYU professor and host of "The Prof G Pod" podcast, believes Social Security should be means-tested—meaning wealthier individuals shouldn't receive benefits just because they paid in. He argues that he pays the same amount in Social Security taxes as someone making $160,000 a year.&nbsp;
"So I have analysts working here at ProfG who make 160 grand. So they make, or they pay $9,000 in social security tax. I make 16 million and I pay $9,000. Why on earth are the rich not paying their share to support our seniors? So if you&#8217;re going to continue to transfer this much money to seniors and you think it&#8217;s a good idea, fine," Galloway said.
His take? Social Security is a tax meant to support those who need it, and high earners like himself don't necessarily need the extra money.
Not everyone agrees. According to<a href="https://www.cbpp.org/research/social-security/means-testing-social-security-the-challenges-ahead"> the Center on Budget and Policy Priorities</a>, means-testing could actually weaken Social Security. One of the program's biggest strengths is that it's universal—everyone pays in, and everyone gets something back.&nbsp;
If benefits get cut for high earners, Social Security might start looking like a welfare program, making it an easier target for budget cuts down the line.
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Beyond Social Security, Galloway has strong opinions on <a href="https://www.benzinga.com/startups/25/01/43416787/the-5-million-lunch-that-changed-it-all-how-ted-weschler-met-warren-buffett-and-built-a-269-million-retirement-account">retirement</a> investing. In his book, "The Algebra of Wealth," he warns that putting too much money into risky investments—like growth stocks and derivatives—can be a huge mistake.&nbsp;
"Diversification is the kevlar that protects you—with it, bad decisions will still hurt, but they won't prove fatal," he said, arguing that if all your savings are in just a few risky assets, a bad bet could wipe you out. He stresses that the goal isn't to chase the biggest returns—it's to build long-term security.
Still, some experts think a little risk is necessary. <a href="https://investor.vanguard.com/investor-resources-education/education/model-portfolio-allocation">Per Vanguard</a>, a well-balanced mix of stocks and bonds tends to generate the best long-term returns, and having some exposure to growth stocks can actually boost wealth over time.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/millionaires-never-earned-six-figures-according-to-dave-ramsey">69% of Millionaires Never Earned A Six-Figure Salary – Here Are 2 Things They Do To Get Their First $1 Million, According To Dave Ramsey</a></li>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>

Personal Finance

Scott Galloway Urges 'Means-Testing' For Social Security – 'I Make $16M A Year, I Shouldn't Get A Check'

Many of the top-performing stocks and assets in recent years have stumbled at the start of 2025, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dropping to <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43987636/bitcoin-tumbles-below-85000-amid-president-trumps-eu-tariff-threats">a three-month low.</a>
Here's a look at the year-to-date performance of top 2024 assets and what's outperforming them.
What Happened: Bitcoin was a top performer in 2024, rising over 100% and hitting multiple all-time highs throughout the year, including shortly after Donald Trump won the 2024 presidency.
While Bitcoin rebounded in January, the leading cryptocurrency has since reversed course, down 10.4% year-to-date in 2025. Once seen as a hedge against interest rates, inflation, and macroeconomic concerns, Bitcoin is now declining alongside other traditionally perceived safe-haven assets.
Magnificent Seven stocks, which were also top performers in recent years, have also been underperformers in 2025, compared to the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>). Here are the year-to-date returns.
<ul>
<li>Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>): -2.4%</li>
<li>Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>): -5.3%</li>
<li>Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>): -10.4%</li>
<li>Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>): +9.9%</li>
<li>Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>): -6.4%</li>
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>): -12.8%</li>
<li>Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>): -24.5%</li>
</ul>
Compare that to the SPY, which is trading nearly even with its starting year price with a current share price of $585.03. At the time of writing, the ETF is up 39 cents on the year, or 0.07%.
Technology stocks have also outperformed in recent years, helping boost the investment returns of the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>). The ETF, which is heavily weighted in tech stocks, is down 2.0% year-to-date in 2025.
Read Also: <a href="https://www.benzinga.com/trading-ideas/technicals/25/02/44043021/tesla-the-only-magnificent-seven-stock-in-freefall-can-it-reverse-course">Tesla: The Only Magnificent Seven Stock In Freefall &#8211; Can It Reverse Course?</a>
The Outperformers: While Bitcoin, tech and the Magnificent Seven stocks are down year-to-date in 2025, there are several places that are outperforming the broad market.
One of the top places is the Dow Jones Industrial Average, tracked by the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>). The ETF is up 2.1% year-to-date in 2025, outperforming the SPY and QQQ. This often happens during periods of economic uncertainty or when industrial and manufacturing investments are stronger than technology investments.
Of the 30 Dow Jones Industrial Average stocks, 19 are positive year-to-date in 2025—a sharp contrast to the Magnificent Seven, where only one of seven stocks is in the green this year.
Among the Dow Jones Industrial Average stocks, these are the top gainers year-to-date that are each up by double digits:
<ul>
<li>Amgen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>): +17.5%</li>
<li>International Business Machines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>): +16.4%</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>): +14.2%</li>
<li>Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>): +13.7%</li>
<li>Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>): +12.8%</li>
<li>Visa Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>): +10.9%</li>
</ul>
Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>, NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) shares are up 12.3% year-to-date in 2025, despite struggles from its top portfolio holding, Apple. The Warren Buffett-led conglomerate has a history of outperforming the S&amp;P 500, and 2025 could be another strong year.
Perhaps among the bigger surprises for outperformers in 2025 are Chinese stocks. Using <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1">the Benzinga Pro </a>screener tool and looking for the top performing stocks year-to-date with market capitalizations of $1 billion or more revealed Xpeng Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) and Alibaba Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) among the top performers up 82% and 57% respectively.
Chinese ETFs are also performing well in 2025, here are the returns of some of the largest:
<ul>
<li>KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>): +17.4%</li>
<li>iShares China Larce-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NYSE">FXI</a>): +17.2%</li>
<li>iShares MSCI China ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHI#NASDAQ">MCHI</a>): +15.9%</li>
</ul>
The strong returns of several Chinese stocks and the ETFs come as the country faces<a href="https://www.benzinga.com/news/global/25/02/44010093/trumps-plan-for-canada-mexico-china-tariffs-to-start-march-4-could-shake-stock-market"> proposed additional tariffs</a> from President Donald Trump.
With only two months of 2025 behind us, the landscape could change significantly in the next 10 months.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/43403758/exclusive-this-magnificent-7-stock-will-feel-the-pinch-of-feds-rate-decision-poll-shows">EXCLUSIVE: This &#8216;Magnificent 7&#8217; Stock Will Feel The Pinch Of Fed&#8217;s Rate Decision, Poll Shows</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Tech

$BTC

AAPL

AMGN

AMZN

BABA

GOOG

GOOGL

KWEB

MCHI

MSFT

NVDA

XPEV

Bitcoin, Magnificent 7 Lose Safe-Haven Status In 2025 As China ETFs, Dow Stocks Outperform

BLND

Blend Labs shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results.

Cryptocurrency markets are rebounding from an overnight dip that saw Bitcoin go <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44039431/bitcoin-plummets-below-80000-ethereum-xrp-dogecoin-get-hammered-as-crypto-crash-continues">as low as $78,300</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$84,650.16</td>
<td>+1.7%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,233.35</td>
<td>-1.7%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$146.31</td>
<td>+8.3%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.15</td>
<td>-0.7%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.2013</td>
<td>-0.9%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001389</td>
<td>-2.8%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume decreasing by 26.1%. Daily active addresses grew by 6.3%. Transactions greater than $100,000 are down from 13,305 to 12,754 in a single day. Exchanges netflows are down by 148.7%.</li>
<li>Coinglass data reports 233,253 traders were liquidated in the past 24 hours for $1.01 billion.</li>
<li>IntoTheBlock data shows Bitcoin's active addresses reached the highest daily level since December 2024. Spikes in on-chain activity coincides with market peaks and bottoms. This surge implies the market could be at a crucial turning point.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44048486/bitcoins-24-correction-mostly-technical-say-experts">Bitcoin&#8217;s 24% Correction &#8216;Mostly Technical&#8217; Say Experts</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44050992/the-real-reason-why-bitcoin-is-down-14-in-7-days-and-may-go-down-more">The Real Reason Why Bitcoin Is Down 14% In 7 Days (And May Go Down More)</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44041389/bitcoin-will-still-hit-500000-before-trump-leaves-office-standard-chartered-analyst-maintains">Bitcoin Will Still Hit $500,000 Before Trump Leaves Office, Standard Chartered Analyst Maintains</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44046215/bitvm-integration-unlocks-bitcoins-19-trillion-liquidity-across-five-major-blockchains">BitVM Integration Unlocks Bitcoin&#8217;s $1.9 Trillion Liquidity Across Five Major Blockchains</a></li>
<li><a href="https://www.benzinga.com/25/02/44032261/michael-saylor-advocates-for-us-leadership-in-bitcoin-and-crypto-to-house-financial-services-committee">Michael Saylor Presents &#8216;Digital Assets Framework&#8217; To House Committe, Pitches For US Supremacy In Bitcoin, Crypto</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Berachain (CRYPTO: BERA)</td>
<td>&nbsp;$8.41</td>
<td>+12.4%</td>
</tr>
<tr>
<td>Celsetia (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TIA</a>)</td>
<td>&nbsp;$4.05</td>
<td>+12.3%</td>
</tr>
<tr>
<td>Hedera (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/hbar/usd">HBAR</a>)</td>
<td>&nbsp;$0.2151</td>
<td>+10%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: BTC has fallen 19% over the past week, prompting trader Altcoin Sherpa to question whether a short-term recovery is possible.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Lets see if we can break this cycle of poverty in the short term for <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> <a href="https://t.co/ZWhyzAsXXz">pic.twitter.com/ZWhyzAsXXz</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1895533795186774154?ref_src=twsrc%5Etfw">February 28, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Santiment data highlights how traders consistently misjudge BTC's direction. Mentions of $70,000-$75,000 (bearish) and $90,000-$95,000 (bullish) indicate that when traders expect BTC to rise, it falls—and vice versa.
Trader Blockchainedbb points to liquidity above $107,000, with $110,000 as the next major profit-taking zone. Meanwhile, CrediBULL Crypto sees relief after BTC tagged $79,000, expecting a base to form between $74,000 (HTF demand) and $94,000-$99,000 (local supply) before a full reversal.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">More like 2025! Liquidity above 107k ! Around 110k ish is next major profit taking <a href="https://t.co/LDM2mEVSMH">https://t.co/LDM2mEVSMH</a> <a href="https://t.co/GQeVR1xgOF">pic.twitter.com/GQeVR1xgOF</a>
&mdash; Blockchainedbb (@blockchainedbb) <a href="https://twitter.com/blockchainedbb/status/1895558550178734140?ref_src=twsrc%5Etfw">February 28, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44044388/michael-saylor-says-sell-a-kidney-but-keep-the-bitcoin-but-mstr-is-down-28-since-he-appeared-on-the-cover-of-forbes">Michael Saylor Says &#8216;Sell A Kidney, But Keep The Bitcoin&#8217;, But MSTR Is Down 28% Since He Appeared On The Cover Of Forbes</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$ETH

$HBAR

$SHIB

$SOL

$TIA

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Rebound From The Brink: Here Are The Key Levels To Watch

Ukraine&#8217;s President Volodymyr Zelenskyy met with President Donald Trump and Vice President JD Vance on Friday but left the White House without signing an <a href="https://www.benzinga.com/news/global/25/02/44053592/white-house-meeting-turns-tense-as-trump-warns-zelenskyy-youre-gambling-with-world-war-iii">agreement for rare minerals</a>.
The meeting, originally set to finalize the deal over critical minerals as a form of repayment for military aid, escalated into a heated exchange as Trump accused the Ukrainian leader of<a href="https://www.benzinga.com/news/global/25/02/44053592/white-house-meeting-turns-tense-as-trump-warns-zelenskyy-youre-gambling-with-world-war-iii"> "gambling with World War III."</a>
"You're either going to make a deal or we're out," Trump noted. "And if we're out, you'll fight it out and I don't think it's going to be pretty."
Trump&#8217;s administration moved to sign the proposal earlier this month, but <a href="https://www.benzinga.com/markets/commodities/25/02/43788546/ukraine-officials-stall-trumps-colonial-rare-earths-bid-prefer-mutually-beneficial-deal">Ukrainian officials stalled</a>. They called the bid exploitative and rushed and stated that Kyiv could not accept it in that form.
After weeks of negotiation, the two parties found common ground, dropping Trump&#8217;s original $500 billion proposal but <a href="https://www.benzinga.com/25/02/43968607/trump-negotiates-a-very-big-deal-for-ukraines-mineral-wealth">not including security guarantees</a> — one of Kyiv&#8217;s key demands, which Trump wanted to address "later on." According to the Kiel Institute for the World Economy, the U.S. donated $118 billion during the three-year conflict.
Rare earth minerals are used in numerous modern technologies, from electric vehicles to defense systems. Per EU classifications, Ukraine holds deposits of 22 out of 34 of those minerals. Still, in a war-ridden country, getting to those minerals might be an issue.
According <a href="https://www.aljazeera.com/news/2025/2/28/mapping-ukraines-rare-earth-and-critical-minerals">to</a> Al Jazeera, most of those deposits are in Luhansk, Donetsk, Zaporzhizhia, Dnipropetrovsk, Korovohrad, Poltava and Kharkiv, with the Russian Federation controlling about 40% of them.
Besides the war factor, BCA Research Chief Strategist Marko Papic noted yet another issue.
"Even if you somehow manage to get the rare earths out, the question would be — where do you refine them? And the fact is that most of them would have to go to China. I mean, that&#8217;s the critical bottleneck in this whole situation," he <a href="https://www.linkedin.com/posts/marko-papic-geopolitics_does-the-rare-earth-deal-matter-im-out-activity-7301045940683997184-YB4b?">said</a> on LinkedIn.
Furthermore, Papic sees the entire situation as Trump&#8217;s way of garnering domestic support.
"I think it&#8217;s the way to effectively build domestic political consensus for continued support of Ukraine. Many of his voters, many of his supporters, many conservatives in the U.S., specifically Republican voters, are increasingly becoming skeptical of continued support for Ukraine. Polling shows that the vast majority believe that Ukraine&#8217;s aid has already been too much. Therefore, this is the way for President Trump to do something domestically," he noted, pointing at the parallels with the USMCA agreement from 2020.
"This is something that President Trump does over and over again. The theater surrounding many of his deals, the back and forth, calling countries bad names, saying they should be states of the United States &#8230; that&#8217;s in many ways designed to build domestic consensus, particularly among his voters," Papic concluded
Read Next: • <a href="https://www.benzinga.com/media/25/02/44052145/taiwan-semi-faces-geopolitical-strain-due-to-us-scrutiny-on-huaweis-chip-access">Taiwan Semi Faces Geopolitical Strain Due To US Scrutiny On Huawei&#8217;s Chip Access</a>

Commodities

Politics

Global

'This Is Something That President Trump Does Over And Over Again,' Geopolitical Strategist Says About Failed Rare Minerals Deal With Ukraine President Zelenskyy

Comments

Aquaron Acquisition Corp. - Rights

Aquaron Acquisition Corp. - Rights (AQUNR) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL